text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "natural"

46 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1
  • 2(current)
  • 3

You searched for "natural"

476 Documents found
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • White Paper - PyroGene® Recombinant Factor C Assay – Endotoxin Testing: It's Time to Embrace the 'Alternative'
    This white paper addresses topics such as: the growing demand of a natural resource, benefits of the synthetic version of Factor C and how to validate the PyroGene® rFC Assay.
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • Amazon Gift Card Giveaway T&Cs
    Terms and conditions for neural survey giveaway
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • Basic Transfection Protocol for Neural Cells (Adher.) - 4D-Nucleofector™ Device
    Instructions of use for transfection of adherent primary mammalian neurons with the Basic Neuron 4D-Nucleofector™ X Kit
  • Basic Transfection Protocol for Neural Cells - 4D-Nucleofector™ Device
    Instructions of use for transfection of primary mammalian neurons with the P3 Primary Cell 4D-Nucleofector™ X Kit
  • Cryopreserved Neural Cells and Media
    Lonza's Cryopreserved Neurons Offer Comparable Results to Fresh Cells
  • Basic Transfection Protocol for Neural Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of primary mammalian neurons with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Instructions - Neural Progenitor Cell System, NHNP
    Instructions for Proper Use
  • TechSheet - Neural Progenitor Cell System, NHNP
    Technical Product Information Sheet
  • SeaPure Agarose PDS
    Lonza Product DataSheets - SeaPure Agarose
  • A Serum-free Chemically Defined Medium for the Expansion of NHDF-Adult
    Traditionally, in vitro cell culture medium contains animal-derived products like serum, tissue extracts or hydrosylates. They are also a source of undesirable factors, such as endotoxin, and pose potential BSE risks. The undefined and variable nature of these components is a challenge in basic research and applied biomedical sciences. Lonza has developed a serum-free chemically defined, fibroblast growth medium, to propagate primary adult normal human dermal fibroblasts (NHDF).
  • Nucleofector® Technology and Genome Editing
    An Introduction to Nucleofection® and CRISPR
  • SourceBook Appendix B - Agarose Physical Chemistry
    1. Agarose Physical Chemistry 2. References
  • 1(current)
  • 2
  • 3